ARTIVION, INC. (AORT)
About ARTIVION, INC.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $441.3M
- Net income
- $9.8M
- Total assets
- $884.8M
- Market cap
- $976.7M
- Gross margin
- 64.4%
- Operating margin
- 7.6%
- Net margin
- 2.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $441.3M
- Cost of revenue
- $157.1M
- Gross profit
- $284.2M
- Operating expenses
- $257.5M
- Operating income
- $33.7M
- Income tax
- $5.0M
- Net income
- $9.8M
- EPS (basic)
- $0.22
- EPS (diluted)
- $0.21
Balance sheet
- Total assets
- $884.8M
- Current assets
- $358.1M
- Total liabilities
- $436.6M
- Current liabilities
- $101.6M
- Shareholders’ equity
- $448.2M
Cash flow
- Operating cash flow
- $39.9M
- Investing cash flow
- -$42.0M
- Financing cash flow
- $11.3M
- Net cash flow
- $11.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $976.7M
- P/E ratio
- 120.4
- EPS (diluted)
- $0.21
- Dividend yield
- 0.47%
- Shares outstanding
- 38.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 11, 1993
Artivion, Inc. (AORT) Stock Price
- Profitable — net income of $9.8M in FY2025.
- Revenue grew 41% from FY2022 to FY2025.
- Gross margin of 64.4%, net margin 2.2%.
- Trading 47% below its 52-week high.
- Pays a dividend yielding about 0.47% annually.
- Valued at a price-to-earnings (P/E) ratio of 120.4.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ARTIVION, INC..
Write a review
News about ARTIVION, INC.
News & sentiment via Polygon.io
Artivion, Inc.: frequently asked questions
Is Artivion, Inc. an American company?
Artivion, Inc. is a US-based company headquartered in Kennesaw, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Artivion, Inc. headquartered?
Artivion, Inc. is headquartered in Kennesaw, Georgia, United States.
Is Artivion, Inc. publicly traded?
Yes — Artivion, Inc. is a publicly traded company. Its stock trades under the ticker symbol AORT on the NYSE.
What does Artivion, Inc. do?
Artivion, Inc. is an American Medical Devices company in the Health & Beauty sector.
